Cargando…
Biomarkers in Pneumonia—Beyond Procalcitonin
Pneumonia is the leading infectious cause of mortality worldwide and one of the most common lower respiratory tract infections that is contributing significantly to the burden of antibiotic consumption. Due to the complexity of its pathophysiology, it is widely accepted that clinical diagnosis and p...
Autores principales: | Karakioulaki, Meropi, Stolz, Daiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514895/ https://www.ncbi.nlm.nih.gov/pubmed/31022834 http://dx.doi.org/10.3390/ijms20082004 |
Ejemplares similares
-
Biomarkers and clinical scoring systems in community-acquired pneumonia
por: Karakioulaki, Meropi, et al.
Publicado: (2019) -
Extracellular matrix remodelling in COPD
por: Karakioulaki, Meropi, et al.
Publicado: (2020) -
The Role of Atopy in COPD and Asthma
por: Karakioulaki, Meropi, et al.
Publicado: (2021) -
Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea—a prospective intervention study
por: Karakioulaki, Meropi, et al.
Publicado: (2021) -
Endothelial dysfunction is not a predictor of outcome in chronic obstructive pulmonary disease
por: Scherr, Andreas, et al.
Publicado: (2020)